Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$428M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$232M |
| 3 |
Grayscale Bitcoin Trust
GBTC
|
+$208M |
| 4 |
Morgan Stanley Direct Lending Fund
MSDL
|
+$201M |
| 5 |
Infosys
INFY
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$50.9B |
| 2 |
Apple
AAPL
|
+$38.9B |
| 3 |
Amazon
AMZN
|
+$26B |
| 4 |
NVIDIA
NVDA
|
+$23.3B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 10.81% |
| 3 | Healthcare | 9.76% |
| 4 | Consumer Discretionary | 9.08% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5601
Belpointe PREP
OZ
$182M
| $183K | ﹤0.01% |
3,011
-4,867
| -62% | -$304K |
|
5602
Lee Enterprises
LEE
$181M
| $183K | ﹤0.01% |
13,734
-26,584
| -66% | -$278K |
|
|
SHCO
5603
DELISTED
Soho House & Co
SHCO
| $182K | ﹤0.01% |
32,018
-39,114
| -55% | -$237K |
|
|
NSLR
5604
Neostellar Capital Corp
NSLR
$295M
| $181K | ﹤0.01% |
39,793
-173,473
| -81% | -$709K |
|
5605
Aveanna Healthcare
AVAH
$2.04B
| $181K | ﹤0.01% |
72,555
-128,601
| -64% | -$310K |
|
5606
Aprea Therapeutics
APRE
$7.42M
| $179K | ﹤0.01% |
26,818
-7,618
| -22% | -$47.3K |
|
5607
Personalis
PSNL
$1.44B
| $179K | ﹤0.01% |
119,906
-126,838
| -51% | -$196K |
|
5608
Direxion Daily Junior Gold Miners Index Bear 2X ETF
JDST
$27.5M
| $178K | ﹤0.01% |
182
-999
| -85% | -$1.3M |
|
5609
Catalyst Bancorp
CLST
$67.6M
| $178K | ﹤0.01% |
+15,000
| New | +$178K |
|
5610
TMC The Metals Company
TMC
$1.71B
| $177K | ﹤0.01% |
123,482
-77,674
| -39% | -$108K |
|
|
MTLS
5611
Materialise
MTLS
$388M
| $175K | ﹤0.01% |
33,149
-33,101
| -50% | -$186K |
|
5612
Fossil Group
FOSL
$360M
| $172K | ﹤0.01% |
168,991
-1,423,165
| -89% | -$1.59M |
|
5613
Citius Pharmaceuticals
CTXR
$17.1M
| $172K | ﹤0.01% |
7,667
-11,850
| -61% | -$216K |
|
5614
Global X Emerging Markets Bond ETF
EMBD
$249M
| $171K | ﹤0.01% |
+7,573
| New | +$168K |
|
5615
FT Vest US Equity Buffer ETF February
FFEB
$1.4B
| $171K | ﹤0.01% |
3,778
-4,094
| -52% | -$180K |
|
5616
Riverview Bancorp
RVSB
$110M
| $170K | ﹤0.01% |
35,975
-37,709
| -51% | -$196K |
|
|
SY
5617
So-Young International
SY
$200M
| $170K | ﹤0.01% |
155,525
-124,325
| -44% | -$131K |
|
5618
iShares ESG Advanced MSCI EAFE ETF
DMXF
$1.01B
| $170K | ﹤0.01% |
2,488
-214
| -8% | -$14K |
|
5619
LiveWire
LVWR
$291M
| $169K | ﹤0.01% |
23,431
-42,641
| -65% | -$409K |
|
5620
Cadeler
CDLR
$2.19B
| $169K | ﹤0.01% |
9,327
-54,627
| -85% | -$963K |
|
5621
Arrow Dow Jones Global Yield ETF
GYLD
$37.5M
| $169K | ﹤0.01% |
12,789
-8,535
| -40% | -$112K |
|
5622
Eastern Company
EML
$149M
| $168K | ﹤0.01% |
4,918
-660
| -12% | -$16.8K |
|
|
KNDI
5623
Kandi Technologies Group
KNDI
$70.3M
| $167K | ﹤0.01% |
78,930
-82,534
| -51% | -$212K |
|
5624
Immix Biopharma
IMMX
$664M
| $166K | ﹤0.01% |
54,045
+21,709
| +67% | +$84.1K |
|
5625
Acme United Corp
ACU
$212M
| $166K | ﹤0.01% |
3,525
-3,447
| -49% | -$156K |
|
Similar funds
Morgan Stanley's Q1 2024 Portfolio in Review
As of Q1 2024, Morgan Stanley held 8,154 positions worth $1.25T, down 45% from $2.27T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Morgan Stanley withdrew a net $1.16T in Q1 2024, closing 331 positions and reducing 6,748 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $725M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Morgan Stanley opened a new position in Grayscale Bitcoin Trust worth $270M.
- Morgan Stanley's largest Q1 2024 buy was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M.
- Morgan Stanley added most to Altria Group in Q1 2024, an estimated $428M increase.
- Morgan Stanley's biggest Q1 2024 reduction was Microsoft, cutting an estimated $50.9B.
- Morgan Stanley fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $725M.
- Morgan Stanley's ten largest holdings make up 19% of its $1.25T portfolio in Q1 2024.
- Morgan Stanley opened 333 new positions and closed 331 in Q1 2024.
- Morgan Stanley's portfolio value fell 45% quarter-over-quarter to $1.25T.
Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.